Medical Supervision Required:
Peptide Tracker is for private logging, calculations, reminders, inventory records, and education. It is not medical advice, dosing instruction, prescribing guidance, diagnosis, or a substitute for a qualified healthcare professional.
Resources
Educational guides for keeping clearer GLP-1 and peptide records without turning tracking tools into medical advice.
Basics
Plain-language explainers for terminology, timing math, and recordkeeping boundaries before you get into product-specific pages.
Showing 19 resources
Overview What is a peptide? Published Apr 29, 2026 · 3 minute read Understand amino-acid chains, peptide bonds, peptide-versus-protein wording, product-record boundaries, and tracking context. Overview What is a GLP-1? Published Apr 29, 2026 · 3 minute read Separate natural GLP-1 hormone concepts from GLP-1 receptor agonist medications, half-life references, and recordkeeping. Overview What is bioavailability? Published May 2, 2026 · 4 minute read Learn rate, extent, AUC, first-pass metabolism, route differences, and why records cannot measure personal exposure. Overview What is food noise? Published Jun 29, 2026 · 3 minute read Understand the informal term for intrusive food thoughts, why GLP-1 users report it quieting, and the appetite and reward-pathway science. Overview What is compounded semaglutide? Published Jun 29, 2026 · 3 minute read Learn what pharmacy compounding means, why compounded GLP-1s appeared during shortages, and the FDA's safety and dosing cautions. Overview What is dose titration? Published Jun 30, 2026 · 4 minute read Learn why GLP-1 doses start low and step up, what escalation and maintenance dose mean, and why the label sets the schedule. Overview What is Ozempic face? Published Jun 30, 2026 · 3 minute read Understand the media nickname for facial changes after rapid weight loss, why it is not drug-specific, and the related slang. Overview What is an incretin? Published Jul 1, 2026 · 5 minute read Understand incretin gut hormones, GLP-1 and GIP, the incretin effect, and how they underpin modern GLP-1 medicines. Overview What is GIP? Published Jul 1, 2026 · 4 minute read Learn the second incretin hormone, how GIP differs from GLP-1, and why dual GIP/GLP-1 agonists target it. Overview What is glucagon? Published Jul 1, 2026 · 4 minute read Understand glucagon's role in blood sugar and metabolism, and why triple agonists add glucagon receptor activity. Overview What is MASH? Published Jul 1, 2026 · 4 minute read Learn what MASH (formerly NASH) liver disease is, how it relates to metabolic health, and why GLP-1 trials target it. Overview How long do GLP-1 drugs stay in your system? Published Jul 2, 2026 · 3 minute read Compare GLP-1 half-lives and elimination timelines, from daily Victoza to weekly Ozempic and Mounjaro, and why it varies by drug. Overview Weight regain after stopping GLP-1s Published Jul 2, 2026 · 3 minute read What research shows about regaining weight after stopping GLP-1 drugs, the STEP 1 extension data, and the chronic-condition framing. Overview GLP-1 and muscle loss Published Jul 3, 2026 · 3 minute read Why some weight loss on GLP-1 drugs is muscle, what the research shows, and how protein and resistance training fit in. Overview Oral vs injectable GLP-1 Published Jul 3, 2026 · 3 minute read How oral and injectable GLP-1s differ in absorption, dosing, and bioavailability, and why route changes logistics, not mechanism. Overview GLP-1 vs GLP-2 vs GLP-3 Published May 1, 2026 · 6 minute read Learn what single, dual, and triple agonist labels mean, and compare trial weight-loss data for semaglutide, tirzepatide, and retatrutide. Overview Peptide half-life tracking Published Apr 20, 2026 · 5 minute read Learn the half-life formula, decay curves, accumulation, steady-state estimates, and why modeled levels are not the same as lab results. Overview Peptide tracking for beginners Published Apr 29, 2026 · 3 minute read Start with factual logs, unit clarity, inventory, schedules, injection-site history, half-life charts, and exports. Overview How GLP-1 tracking works Published Apr 20, 2026 · 6 minute read See how logs, reminders, inventory, injection sites, half-life curves, privacy, and exports fit together without replacing care.
GLP-1 Names
Compound and brand name explainers for terms that often get mixed together in everyday GLP-1 discussions.
Showing 34 resources
Compound Names What is semaglutide? Published May 2, 2026 · 5 minute read Learn how semaglutide connects Ozempic, Wegovy, Rybelsus, tablets, injections, GLP-1 wording, and label context. Compound Names What is tirzepatide? Published May 2, 2026 · 4 minute read Separate tirzepatide, Mounjaro, Zepbound, dual GIP/GLP-1 receptor language, diabetes, weight, and OSA labels. Compound Names What is retatrutide? Published May 2, 2026 · 5 minute read Understand Lilly's investigational triple GIP, GLP-1, and glucagon agonist, informal GLP-3 shorthand, and approval boundaries. Compound Names What is CagriSema? Published May 6, 2026 · 7 minute read Separate cagrilintide, semaglutide, amylin-plus-GLP-1 wording, REDEFINE trials, FDA-submission status, and tirzepatide comparisons. Compound Names What is amylin? Published May 6, 2026 · 6 minute read Understand amylin, IAPP, satiety, gastric emptying, pramlintide, cagrilintide, amycretin, and how amylin differs from GLP-1. Compound Names What is survodutide? Published May 6, 2026 · 8 minute read Learn Boehringer Ingelheim's investigational GLP-1/glucagon dual agonist, SYNCHRONIZE obesity data, MASH context, and approval boundaries. Compound Names What is MariTide? Published May 6, 2026 · 6 minute read Understand Amgen's maridebart cafraglutide, monthly dosing research, GLP-1 agonism, GIP receptor antagonism, and phase 2 evidence. Compound Names What is cagrilintide? Published May 6, 2026 · 8 minute read Learn Novo Nordisk's long-acting amylin analogue, AM833, cagrilintide monotherapy data, and its role in CagriSema. Compound Names What is lixisenatide? Published May 6, 2026 · 8 minute read Separate lixisenatide, Adlyxin, Soliqua 100/33, GLP-1 receptor agonist wording, U.S. discontinuation context, and diabetes labels. Compound Names What is amycretin? Published May 6, 2026 · 8 minute read Understand Novo Nordisk's investigational single-molecule GLP-1 and amylin receptor agonist, oral and injectable studies, and status. Compound Names What is mazdutide? Published May 6, 2026 · 7 minute read Learn Innovent's China-approved GLP-1/glucagon dual agonist, IBI362, GLORY-1 data, NMPA approvals, and U.S. approval boundaries. Compound Names What is ecnoglutide? Published May 6, 2026 · 6 minute read Understand Sciwind's China-approved cAMP-biased GLP-1 receptor agonist, XW003, SLIMMER data, and approval geography. Compound Names What is liraglutide? Published May 2, 2026 · 4 minute read Learn how liraglutide connects Victoza, Saxenda, once-daily GLP-1 injections, generic context, and label boundaries. Compound Names What is dulaglutide? Published May 2, 2026 · 5 minute read Learn how dulaglutide connects Trulicity, once-weekly GLP-1 injections, type 2 diabetes, cardiovascular-risk wording, and label context. Compound Names What is orforglipron? Published May 2, 2026 · 4 minute read Separate orforglipron from Foundayo, oral semaglutide, GLP-1 pill shorthand, chronic weight-management approval, and diabetes trial context. Compound Names What is VK2735? Published Jun 22, 2026 · 5 minute read Understand Viking Therapeutics' investigational dual GLP-1/GIP agonist, developed as both a weekly injection and a daily oral tablet, and its VANQUISH and VENTURE trials. Compound Names What is pemvidutide? Published Jun 22, 2026 · 4 minute read Learn Altimmune's investigational balanced GLP-1/glucagon dual agonist (ALT-801), its MASH lead program, Breakthrough Therapy status, and obesity data. Compound Names What is eloralintide? Published Jun 22, 2026 · 4 minute read Understand Eli Lilly's investigational selective amylin receptor agonist (LY3841136), its Phase 2 weight-loss data, and ENLIGHTEN-1 Phase 3 program. Compound Names What is petrelintide? Published Jun 22, 2026 · 4 minute read Learn Zealand Pharma and Roche's investigational long-acting amylin analog (ZP8396), the ZUPREME trials, and the landmark Roche partnership. Compound Names What is MET-097i? Published Jun 22, 2026 · 4 minute read Understand Pfizer's investigational ultra-long-acting GLP-1 (PF-08653944) from Metsera, designed for weekly and monthly dosing, and the VESPER trials. Compound Names What is efinopegdutide? Published Jun 22, 2026 · 4 minute read Learn Merck's investigational GLP-1/glucagon dual agonist (MK-6024), its liver-focused MASH program, and its head-to-head liver-fat data versus semaglutide. Brand Names What is Ozempic? Published May 2, 2026 · 5 minute read Separate Ozempic, semaglutide, tablets, injections, Wegovy, Rybelsus, and type 2 diabetes label context. Brand Names What is Wegovy? Published May 2, 2026 · 5 minute read Understand Wegovy, semaglutide, weight-management labels, tablets, injections, cardiovascular context, and Ozempic confusion. Brand Names What is Rybelsus? Published May 2, 2026 · 6 minute read Learn how Rybelsus, oral semaglutide, Ozempic tablets, Wegovy, type 2 diabetes, and route wording fit together. Brand Names What is Trulicity? Published May 2, 2026 · 5 minute read Separate Trulicity, dulaglutide, GLP-1 class wording, type 2 diabetes label context, Ozempic, and Mounjaro. Brand Names What is Saxenda? Published May 2, 2026 · 5 minute read Understand Saxenda, liraglutide, chronic weight-management labeling, Victoza differences, semaglutide brands, and GLP-1 naming. Brand Names What is Victoza? Published May 2, 2026 · 4 minute read Understand Victoza, liraglutide, type 2 diabetes label context, cardiovascular-risk wording, generic history, and Saxenda differences. Brand Names What is Adlyxin? Published May 6, 2026 · 6 minute read Learn Adlyxin's lixisenatide brand history, FDA approval, U.S. discontinuation context, Soliqua differences, and GLP-1 naming. Brand Names What is Soliqua? Published May 6, 2026 · 7 minute read Understand Soliqua 100/33, insulin glargine, lixisenatide, fixed-ratio combinations, Adlyxin differences, and medication-record context. Brand Names What is Symlin? Published May 6, 2026 · 6 minute read Separate Symlin, SymlinPen, pramlintide acetate, amylin analog wording, mealtime insulin context, and GLP-1 misconceptions. Brand Names What is Xultophy? Published May 6, 2026 · 6 minute read Understand Xultophy 100/3.6, insulin degludec, liraglutide, fixed-ratio combinations, Victoza differences, and Soliqua comparisons. Brand Names What is Mounjaro? Published May 2, 2026 · 5 minute read Understand Mounjaro, tirzepatide, dual GIP/GLP-1 wording, type 2 diabetes labeling, Ozempic, and Zepbound confusion. Brand Names What is Zepbound? Published May 2, 2026 · 3 minute read Learn how Zepbound, tirzepatide, Mounjaro, chronic weight management, OSA, and GLP-1 shorthand fit together. Brand Names What is Foundayo? Published May 2, 2026 · 4 minute read Understand Foundayo/orforglipron, oral non-peptide GLP-1 approval, weight-management label context, and semaglutide-pill confusion.
Comparisons
Side-by-side explainers for the GLP-1 drugs and brands people most often compare.
Showing 3 resources
Comparison Ozempic vs Mounjaro Published Jul 4, 2026 · 3 minute read Compare the two leading type 2 diabetes brands, semaglutide vs tirzepatide, including the SURPASS-2 head-to-head trial. Comparison Semaglutide vs tirzepatide Published Jul 4, 2026 · 3 minute read Compare the single GLP-1 and dual GIP/GLP-1 molecules behind Ozempic, Wegovy, Mounjaro, and Zepbound, with pivotal trial data. Comparison Wegovy vs Zepbound Published Jul 4, 2026 · 3 minute read Compare the two leading weight-management brands, semaglutide vs tirzepatide, with mechanism and pivotal trial data.
Tracking App
Focused app workflow pages for common GLP-1 and peptide records inside Peptide Tracker.
Showing 12 resources
Tracking App Peptide Tracker vs spreadsheet Published Apr 30, 2026 · 4 minute read Compare dedicated app records with spreadsheet rows for logs, reminders, units, inventory, progress, privacy, and exports. Tracking App GLP-1 shot tracking Published Apr 25, 2026 · 6 minute read Record shot dates, times, sites, products, dose fields, missed or late logs, inventory context, and exports. Tracking App GLP-1 dose tracking Published Apr 26, 2026 · 5 minute read Keep dose history, units, schedules, actual logs, concentration notes, inventory links, reminders, and reports organized. Tracking App Semaglutide tracking Published Apr 24, 2026 · 5 minute read Organize semaglutide, Ozempic, Wegovy, and Rybelsus records with reminders, sites, side-effect notes, inventory, and exports. Tracking App Tirzepatide tracking Published Apr 25, 2026 · 6 minute read Track tirzepatide, Zepbound, and Mounjaro records with logs, titration notes, injection sites, health metrics, inventory, and exports. Tracking App Mounjaro tracking Published Apr 23, 2026 · 5 minute read Keep Mounjaro dose logs, injection sites, glucose and lab context, side-effect notes, inventory, and exports together. Tracking App Zepbound tracking Published Apr 22, 2026 · 4 minute read Track Zepbound records for weight-management workflows with shots, sites, symptoms, progress metrics, photos, and reports. Tracking App Wegovy tracking Published Apr 21, 2026 · 5 minute read Organize Wegovy weekly records with progress metrics, injection sites, symptoms, inventory, half-life context, and exports. Tracking App Ozempic tracking Published Apr 22, 2026 · 6 minute read Track Ozempic logs beside user-entered glucose, A1C, lab, symptom, injection-site, inventory, and export records. Tracking App Injection-site records Published Apr 24, 2026 · 5 minute read Track injection-site history, rest-day records, body-area organization, reaction notes, and exportable logs. Tracking App Inventory records Published Apr 21, 2026 · 5 minute read Track vials, pens, stock counts, expiration dates, batch/source notes, test reports, BAC water, and exports. Tracking App Side-effect logs Published Apr 26, 2026 · 4 minute read Record side effects with severity, notes, photos, interventions, active/resolved status, dose context, and reports.